MEK/ERK Signaling in β-Cells Bifunctionally Regulates β-Cell Mass and Glucose-Stimulated Insulin Secretion Response to Maintain Glucose Homeostasis
MEK/ERK Signaling in β-Cells Bifunctionally Regulates β-Cell Mass and Glucose-Stimulated Insulin Secretion Response to Maintain Glucose Homeostasis
复制标题
DOI:
10.2337/db20-1295
复制
发表时间:
2021-07-01
期刊:
影响因子:
7.7
通讯作者:
Ueki, Kohjiro
中科院分区:
文献类型:
--
作者:
Ikushima, Yoshiko Matsumoto;Awazawa, Motoharu;Ueki, Kohjiro
In diabetic pathology, insufficiency in beta-cell mass, unable to meet peripheral insulin demand, and functional defects of individual beta-cells in production of insulin are often concurrently observed, collectively causing hyperglycemia. Here we show that the phosphorylation of ERK1/2 is significantly decreased in the islets of db/db mice as well as in those of a cohort of subjects with type 2 diabetes. In mice with abrogation of ERK signaling in pancreatic beta-cells through deletion of Mek1 and Mek2, glucose intolerance aggravates under high-fat diet-feeding conditions due to insufficient insulin production with lower beta-cell proliferation and reduced beta-cell mass, while in individual beta-cells dampening of the number of insulin exocytosis events is observed, with the molecules involved in insulin exocytosis being less phosphorylated. These data reveal bifunctional roles for MEK/ERK signaling in beta-cells for glucose homeostasis, i.e., in regulating beta-cell mass as well as in controlling insulin exocytosis in individual beta-cells, thus providing not only a novel perspective for the understanding of diabetes pathophysiology but also a potential clue for new drug development for diabetes treatment.